Bruton's Tyrosine Kinase inhibitor
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Bruton's Tyrosine Kinase inhibitor, covering 2017-02-10 to 2019-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease [Phase 1, Phase 2]